$Fluor (FLR.US)$The chart of$Jacobs Engineering (J.US)$is not strong, neither is FLR. You would think the fundamentals remain solid given the strong backlog, but J’s chart suggests waning momentum and distribution, perhaps due to lack of upward momentum. Seems data center construction is also a big deal for FLR?
U.S. Election & Stock Market During U.S. presidential elections, financial markets often experience increased volatility. Key trends include: 1. Market Uncertainty: Investors may react to the uncertainty surrounding potential policy changes, leading to fluctuations in stock prices. 2. Sector Performance: Certain sectors may perform better depending on the candidates’ platforms. For example, healthcare and energy stocks might rea...
Like it, or not? Nuclear Energy, and Uranium, are vital. <~ period. Microsoft’s play to reopen (and rename) Three Mile Island, Gates’ backing of TERRA, Amazon’s deal with TALEN, Google’s with KAIROS,… goin’ nuclear, folks: the cost of entry has gone up, buUut… look for pullbacks, and maybe long-term. The modern Small Modular Reactor (SMR) requires High Assay Low-Enrichment Uranium (HALEU), soOo… keep those Acronyms In Mind (AIM) if you’re in...
Dan’l
OP
70648215
:
It’s been a real deal for short-term trading, too, with crazy high gains on $Oklo Inc (OKLO.US)$ and $Centrus Energy (LEU.US)$ lately, buUut… every penny realized goes into growing my share counts as long-term investments. Example: $NuScale Power (SMR.US)$ NuScale Power’s 20.4 M in revenue this year is expected to be over ten times higher next year, and I’m also buying $Fluor (FLR.US)$, which owns over half.
On Saturday, Donald Trump was shot at a campaign rally in Pennsylvania, which could be a key moment that completely disrupts the US election landscape this year. Following the incident, data from Polymarket shows that Trump's chances of winning the election have skyrocketed to 71%. After shooting, Bitcoin price briefly surpassed $63,000.$Trump Media & Technology (DJT.US)$surged over 70% in Mond...
Insiders selling shares, particularly below current price, may be a negative signal. Despite this, the level of insider ownership indicates alignment with common shareholders. The absence of insider trading in the last quarter and recent transactions make us wary about Fluor.
Despite Fluor's lower than average ROE, the company demonstrates strong earnings growth and financial performance, likely due to high earnings retention and efficient management. Industry forecasts indicate that this earnings growth is expected to continue.
Pre-Market Stock Movers Gapping up $Intel (INTC.US)$popped 2.5% after the chipmaker announced it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years. $Fluor (FLR.US)$Shares climbed 2.4% following an upgrade to buy at UBS. The firm is bullish on the stock thanks to progress on legacy projects a...
Gainers: •$Canoo (GOEV.US)$+71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart) •$Aldeyra Therapeutics (ALDX.US)$+14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial) •$Westport Fuel (WPRT.US)$+10.9% (awarded 38 mln program) •$Greenwich LifeSciences (GLSI.US)$+5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Fluor Stock Forum
During U.S. presidential elections, financial markets often experience increased volatility. Key trends include:
1. Market Uncertainty: Investors may react to the uncertainty surrounding potential policy changes, leading to fluctuations in stock prices.
2. Sector Performance: Certain sectors may perform better depending on the candidates’ platforms. For example, healthcare and energy stocks might rea...
Microsoft’s play to reopen (and rename) Three Mile Island, Gates’ backing of TERRA, Amazon’s deal with TALEN, Google’s with KAIROS,… goin’ nuclear, folks: the cost of entry has gone up, buUut… look for pullbacks, and maybe long-term.
The modern Small Modular Reactor (SMR) requires High Assay Low-Enrichment Uranium (HALEU), soOo… keep those Acronyms In Mind (AIM) if you’re in...
After shooting, Bitcoin price briefly surpassed $63,000. $Trump Media & Technology (DJT.US)$ surged over 70% in Mond...
Gapping up
$Intel (INTC.US)$ popped 2.5% after the chipmaker announced it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years.
$Fluor (FLR.US)$ Shares climbed 2.4% following an upgrade to buy at UBS. The firm is bullish on the stock thanks to progress on legacy projects a...
In reaction to earnings/guidance:
• $Comtech Telecommunications (CMTL.US)$ +2.1%, $Micron Technology (MU.US)$+1.5%
Other news:
• $Amylyx Pharmaceuticals (AMLX.US)$ +9.3% (receives FDA approval for Relyvrio)
• $Ready Capital (RC.US)$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron (APRN.US)$ +2.5% (CFO to resign)
• $Fluor (FLR.US)$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $Immuneering (IMRX.US)$ +1.6% (re...
• $Canoo (GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics (ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel (WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences (GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$)
• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
No comment yet